CYP4B1 polymorphisms and the risk of breast cancer in Chinese women: a case-control study
- PMID: 38041008
- PMCID: PMC10693087
- DOI: 10.1186/s12885-023-11477-y
CYP4B1 polymorphisms and the risk of breast cancer in Chinese women: a case-control study
Abstract
Background: Breast cancer (BC) is one of the malignant diseases threatening the life and health of women worldwide. The CYP4B1 gene was abnormally expressed in BC and was associated with the prognosis of BC patients. This study aimed to explore the relationship between CYP4B1 single nucleotide polymorphisms (SNPs) and BC risk in Chinese women.
Methods: A case-control study of 1,143 women (571 patients and 572 healthy individuals) was conducted. Rs2297813 G/T, rs12142787 G/A, and rs3766197 C/T in CYP4B1 were selected and genotyped by MassARRAY system. The relationships between these SNPs and the risk of BC were assessed by logistic regression analysis. In addition, multi-factor dimensionality reduction (MDR) was used to analyze SNP-SNP interactions.
Results: CYP4B1 rs2297813 had a risk-increasing effect on BC in women with body mass index (BMI) ≤ 24 kg/m2 (OR = 1.72, p = 0.026). CYP4B1 rs12142787 was associated with an increased BC risk in smokers (AA: OR = 1.32, p = 0.045). Among non-drinkers, rs2297813 (OR = 1.69, p = 0.009) and rs12142787 (OR = 1.51, p = 0.020) were related to an increased incidence of BC. CYP4B1 rs3766197 (OR = 1.61p = 0.031) was associated with a higher risk of advanced stages (III/IV stage) of BC. Besides, the contributions of CYP4B1 rs2297813 (OR = 1.55, p = 0.021) and rs12142787 (OR = 1.53, p = 0.033) to BC risk might be associated with more than one birth in patients with BC. The three-locus model consisting of rs2297813, rs12142787, and rs3766197 was regarded as the best predictive model for BC risk.
Conclusion: CYP4B1 SNPs were associated with BC risk in Chinese women, especially in patients with BMI ≤ 24 kg/m2, smokers, non-drinkers, patients in advanced stages (III/IV stage), and patients who reproduced once. These findings shed light on the relationship between CYP4B1 SNPs and BC risk in Chinese women.
Keywords: Breast cancer; CYP4B1; Chinese women; Single nucleotide polymorphisms.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures



Similar articles
-
Impact of MIR31HG polymorphisms on risk of breast cancer in Chinese women.Int J Clin Oncol. 2023 May;28(5):664-679. doi: 10.1007/s10147-023-02323-z. Epub 2023 Mar 8. Int J Clin Oncol. 2023. PMID: 36884100
-
Case-control study on CYP4B1 gene polymorphism and susceptibility to gastric cancer in the chinese Han population.BMC Med Genomics. 2022 Oct 28;15(1):223. doi: 10.1186/s12920-022-01367-w. BMC Med Genomics. 2022. PMID: 36307788 Free PMC article.
-
Impact of METTL3/14/16 Gene Polymorphisms on Risk of Breast Cancer in Chinese Women.Clin Breast Cancer. 2025 Apr;25(3):e260-e269.e19. doi: 10.1016/j.clbc.2024.11.008. Epub 2024 Nov 17. Clin Breast Cancer. 2025. PMID: 39643550
-
Impact of NR5A2 and RYR2 3'UTR polymorphisms on the risk of breast cancer in a Chinese Han population.Breast Cancer Res Treat. 2020 Aug;183(1):1-8. doi: 10.1007/s10549-020-05736-w. Epub 2020 Jun 23. Breast Cancer Res Treat. 2020. PMID: 32572717 Review.
-
Single Nucleotide Polymorphisms as the Efficient Prognostic Markers in Breast Cancer.Curr Cancer Drug Targets. 2021;21(9):768-793. doi: 10.2174/1568009621666210525151846. Curr Cancer Drug Targets. 2021. PMID: 34036920 Review.
Cited by
-
Functional analysis of CYP4B1 enzymes from apes and humans uncovers evolutionary hot spots for adaptations of the catalytical function.PLoS Genet. 2025 Jun 27;21(6):e1011750. doi: 10.1371/journal.pgen.1011750. eCollection 2025 Jun. PLoS Genet. 2025. PMID: 40577420 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous